<SEC-DOCUMENT>0001628280-23-038235.txt : 20231109
<SEC-HEADER>0001628280-23-038235.hdr.sgml : 20231109
<ACCEPTANCE-DATETIME>20231109160906
ACCESSION NUMBER:		0001628280-23-038235
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20231109
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231109
DATE AS OF CHANGE:		20231109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cibus, Inc.
		CENTRAL INDEX KEY:			0001705843
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				271967997
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38161
		FILM NUMBER:		231392426

	BUSINESS ADDRESS:	
		STREET 1:		6455 NANCY RIDGE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		(858) 450-0008

	MAIL ADDRESS:	
		STREET 1:		6455 NANCY RIDGE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Calyxt, Inc.
		DATE OF NAME CHANGE:	20170504
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cbus-20231109.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:196cb9eb-1bde-4e17-8bc6-1a55435101d8,g:12ddaaee-0dde-4278-a13c-9fa8a1d555be,d:d4f598811d284dc4a716d2be58e321ed--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cbus-20231109</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001705843</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cbus-20231109.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001705843</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-09</xbrli:startDate><xbrli:endDate>2023-11-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="id4f598811d284dc4a716d2be58e321ed_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report: (Date of earliest event reported):  <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">November 9, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Cibus, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-38161</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">27-1967997</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction<br/>of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:48.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">6455 Nancy Ridge Drive</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">CA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">92121</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Zip Code)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">858</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">450-0008</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of exchange<br/>on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Class A Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">CBUS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">o</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id4f598811d284dc4a716d2be58e321ed_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02. &#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 9, 2023, Cibus, Inc. (the &#8220;Company&#8221;) announced its financial results for the three months ended September 30, 2023. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. <br/><br/>The information in Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing, regardless of any general incorporation language in any such filing, unless the Company expressly sets forth in such filing that such information is to be considered &#8220;filed&#8221; or incorporated by reference therein.<br/></span></div><div id="id4f598811d284dc4a716d2be58e321ed_10"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) Exhibits</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.355%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="cbus-20230930xpr.htm">Press Release, dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="cbus-20230930xpr.htm">November</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="cbus-20230930xpr.htm"> 9, 2023</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id4f598811d284dc4a716d2be58e321ed_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, Cibus, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated: November 9, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CIBUS, INC.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Rory Riggs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rory Riggs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer and Chairman</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>cbus-20230930xpr.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ibe6757d4542747768b7e3606b76bd68b_1"></div><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:125%">Cibus Reports Third Quarter 2023 Financial Results and Provides Business Update </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%"> </font></div><div style="text-align:center"><font><br></font></div><div id="ibe6757d4542747768b7e3606b76bd68b_65"></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">During the 2023 field season, Cibus completed extensive field trials for its three developed traits, PSR in canola and HT1 and HT3 in rice.  </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Company also reports continued progress of Cibus&#8217; high-throughput soybean editing system and its two advanced traits for Sclerotinia resistance and HT2.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Initial UK field trials for its PSR trait in WOSR are underway in conjunction with positive tailwinds in European regulatory progress&#59; accelerating Cibus&#8217; PSR trait in the European market.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Launched strategic realignment and cost savings initiatives to direct focus towards advancing late-stage activities, aligning with its primary commercial objectives.<br><br></font></div><div id="ibe6757d4542747768b7e3606b76bd68b_72"></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Management to host a conference call webcast Thursday, November 9th at 4&#58;30 p.m. ET<br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> <br></font></div><div id="ibe6757d4542747768b7e3606b76bd68b_79"></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:107%">SAN DIEGO, November 9, 2023 &#8211; Cibus, Inc. (Nasdaq&#58; CBUS) (the Company), </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">a leading agricultural technology company that develops and licenses plant traits to seed companies</font><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">, today announced its financial results for the quarter ended September&#160;30, 2023, and provided a business update.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Summary Update</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:12.03pt">Continued progress toward the commercialization of pod shatter reduction (PSR) trait in canola and winter oilseed rape (WOSR)</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.75pt">Continued transfers of elite PSR edited canola and WOSR lines including Cibus gene-edited traits back to customers</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:112%;position:relative;top:-4.2pt;vertical-align:baseline">1  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">for pre-commercialization testing</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.75pt">Of 10 customers, 2 transfers completed by third quarter 2023</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.75pt">Commenced PSR field trials for WOSR in the UK</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:12.03pt">Continued progress toward the commercialization of HT1 and HT3 in rice</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.75pt">Large increase in customer base in North and South America</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.75pt">Acreage potential from these customers exceeds 5 million</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:12.03pt">Continued progress in developing the Company's soybean single cell operating system</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.75pt">Key work on soybean operating system expected in the fourth quarter of 2023, with the system projected to come fully online during 2024</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:12.03pt">Continued positive developments in gene editing regulations</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:14.81pt">The UK approved a law to exempt genome-edited crops from genetically-modified organism </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">GMO) regulations</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.75pt">The EU recently published proposed regulations that would also treat certain gene edited lines in a similar way to conventional breeding</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> See &#8220;About the Trait Machine System (the &#34;Trait Machine&#8482;&#34;)&#8221; for information regarding our initial customer relationships.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Management Commentary</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#34;We have been laser focused on driving our evolution from an R&#38;D company to a commercial company,&#34; said Rory Riggs, Co-Founder, Chairman, and CEO of Cibus. &#34;Our most important milestone to date has been the ongoing advancement of our commercialization efforts for our trait pipeline expansion efforts. We are pleased with the progress we have made in both canola and rice. In canola, for our pod shatter reduction trait, we have ten customers that have sent us their elite germplasm for editing. We are advancing the edited germplasm for each customer line and began transferring their germplasm back to them. As of the end of September, we have returned elite germplasm with our edits to customers in both rice and canola. In rice, we continue to grow our customer base for HT1 and HT3, and have also initiated collaborations with customers in South America, representing millions of acres of rice.&#34;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Peter Beetham, President and COO of Cibus, commented, &#34;The third quarter is an important period for field studies. This summer, we successfully completed field trials for our three developed traits &#8212; pod shatter reduction in canola, HT1, and HT3 in rice. The preliminary data observations are encouraging and is further validation of the technology behind our Rapid Trait Development System&#8482; or </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:125%;position:relative;top:-4.2pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(RTDS). We continue to advance our </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">Sclerotinia </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">trait pipeline and planted our first field testing across multiple locations this past summer to enable validation and performance trialing of our various modes of action as they advance through the pipeline.&#34;  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Mr. Riggs concluded, &#34;We are ending the quarter with significant progress toward the commercialization of our three developed traits in canola and rice and the advancement of our two others under development. We have also witnessed important milestones in the global regulation of gene editing and believe we are at a historic inflection point in gene editing in agriculture where, for the first time, we are seeing the development and commercial advancement of gene edited traits in important crops.&#34;<br></font><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%"><br></font></div><div id="ibe6757d4542747768b7e3606b76bd68b_86"></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:107%">Major Milestones Achieved in 2023<br><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%;text-decoration:underline">Trait Platform Pipeline (3 Crops&#47;5 Traits)<br><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:12.03pt">The Company is successfully returning back to customers their elite germplasm bearing the Company's traits and continues to receive additional elite germplasm for editing and advancing its developed traits.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.9pt">As of Q3 2023, Cibus has received elite germplasm from 10 customers for its PSR trait and now has 3 customers for its rice herbicide traits in North and South America.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:12.03pt">D</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">uring the 2023 field season, Cibus completed extensive field trials for its 3 developed traits, PSR in canola and HT1 and HT3 in rice. Preliminary data observations are encouraging. The canola PSR and rice HT1 and HT3 traits are now advanced in customer genetics, and canola hybrids and rice varieties are being produced in winter nurseries for customer pre-commercial performance evaluation in 2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">New legislation in the UK has enabled research and development of gene edited varieties. Under these new provisions, the Company initiated field trials in the UK for our PSR trait in WOSR in Q3 2023 opening potential for customer expansion of Cibus PSR traits.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">New legislative initiatives in the EU continue legislative momentum toward the treatment of &#34;conventional-like&#34; gene edited traits that do not involve transgenes as conventional varieties.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">Cibus established its first multi-locational field testing network for </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> (White Mold) resistance testing of its trait pipeline. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:12.03pt">In canola, for its advanced traits, Cibus continues work for additional modes of action for </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> resistance and edits for HT2 remain on track in advancing the Company's development pipeline.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Corporate</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">Recent years have seen the introduction of policies advancing the use of gene editing in multiple countries around the world. On July 5th, the EU College of Commissioners adopted the European Commission proposal on the regulation of plants obtained from New Genomic Techniques (NGTs). The proposed regulation identifies a &#8216;Conventional-like&#8217; category of NGT products that would be regulated in a similar manner as conventional varieties, bringing EU policy closer to that of trading customers in North and South America, Australia, and Japan. In the proposal, the Commission highlights the potential of NGTs to contribute to more sustainable agriculture, climate resilience, and food security. Under this proposal, products from the Company's gene editing platform would be considered &#8216;Conventional-like'.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">In October, Cibus underwent a strategic realignment to focus on its primary commercial goal of advancing late-stage activities. The Company's operations are now centered on completing the launch of its initial 3 traits, PSR, HT1, and HT3, within its crop programs for canola&#47;WOSR and rice. This shift also aligns with Cibus' focus on the advancement of its soybean platform and the further development of its </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:107%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> resistance trait and HT2 trait in canola&#47;WOSR, and soybean. Cibus believes that this refocusing on its strengths and top priorities positions it well to achieve its strategic objectives.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">As part of this strategic realignment, the Company initiated prudent cost reduction measures aimed at preserving capital resources for the advancement of its priority objectives. Considering the anticipated cost savings, and without accounting for potential financing transactions, the Company expects that its existing cash and cash equivalents will cover planned operating expenses and capital expenditure needs early </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">into the first quarter of 2024. Cibus actively evaluates capital markets conditions and funding opportunities on an ongoing basis. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">In August 2023, Steve Berreth was appointed General Counsel and Corporate Secretary at Cibus, having previously served as the Vice President, General Counsel, and Secretary at Syngenta Crop Protection LLC, a subsidiary of Syngenta AG, one of the world&#8217;s largest biotechnology agribusinesses. Leveraging his extensive industry expertise, Mr. Berreth is poised to play a pivotal role in driving the Company's growth and commercial development. His experience in overseeing global legal and licensing teams at Syngenta, especially within the seed industry and the large trait royalty business, positions him to make valuable contributions to the Company's future success.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div id="ibe6757d4542747768b7e3606b76bd68b_92"></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:107%">Future 2023 Milestones</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">Cibus has several important development and commercial milestone targets&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">Enabling regeneration of soybean plants from single cells is expected to be completed in the fourth quarter of 2023, with initial edits and improvements of this system projected during 2024. <br><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">Transfer its PSR trait in up to 4 additional elite germplasm of additional seed company customers.<br><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">Additional rice customers for HT1 and HT3 in South America and successful transfer of their elite germplasm to Cibus.</font></div><div><font><br></font></div><div id="ibe6757d4542747768b7e3606b76bd68b_99"></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:107%">Third Quarter 2023 Financial Results</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">Cash position&#58;&#160;Cash and cash equivalents as of September&#160;30, 2023, was $31.9 million. The Company believes cash and cash equivalents will enable Cibus to fund planned operating expenses and capital expenditure requirements</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> into the first quarter of 2024</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">.<br> <br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">Research and development (R&#38;D) Expense&#58;&#160;R&#38;D expense was $17.5 million for the quarter ended September&#160;30, 2023, compared to $3.0 million in the year-ago period. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">The increase of </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">$14.5 million is primarily related to increased lab supply and facility expenses, an increase in employee headcount, and an increase in stock-based compensation expense for restricted stock award grants. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%"><br><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">Selling, general, and administrative (SG&#38;A) expense&#58; SG&#38;A expense was $8.8 million for the quarter ended September&#160;30, 2023, compared to $3.3 million in the year-ago period. The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">increase </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">of $5.5 million is primarily related to an increase in headcount, increased consulting and legal fees, and an increase in stock-based compensation expense for restricted stock award grants.<br><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">Non-operating income (expenses)&#58; Non-operating income was $(0.9) million for the quarter ended September&#160;30, 2023, compared to $0.3 million in the year-ago period. The decrease of $1.2 million in non-operating income is due to changes in the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">fair </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">value of the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">liability classified </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">Class A common stock warrants. <br><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">Net loss&#58;&#160;Net loss was $34.5 million for the quarter ended September&#160;30, 2023, compared to $6.0 million in the year-ago period.<br><br></font></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%;padding-left:12.03pt">Net loss per share of Class A common stock was $(1.59) for the quarter ended September&#160;30, 2023, compared to $(6.36) in the year-ago period.<br><br></font></div><div id="ibe6757d4542747768b7e3606b76bd68b_106"></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:95%">Conference Call and Webcast Information<br><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:95%">Cibus will host a live webcast, Thursday, November 9, 2023, at 4&#58;30 p.m. Eastern Standard Time to discuss its third quarter 2023 financial results and provide a business update. The conference call can be accessed live over the phone by dialing (877) 243-8548 or for international callers by dialing (312) 281-2974. A replay of the call will be available through November 23, 2023 by dialing (844) 512-2921 or for international callers by dialing (412) 317-6671&#59; the passcode is 22028314.<br><br>A live audio webcast of the call will be available under &#34;News &#38; Events&#8221; in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.<br><br></font></div><div id="ibe6757d4542747768b7e3606b76bd68b_113"></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:107%">About the Trait Machine System (the Trait Machine&#8482;)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">The Trait Machine is a dedicated semi-automated end-to-end process for precision gene editing that delivers trait products that integrate into our seed company customers' breeding programs. It is a process of gene editing at scale and speed that uses the world&#8217;s best crop genetics (a seed company&#8217;s elite germplasm or seeds). The Trait Machine is based on the Company's proprietary Rapid Trait Development System&#8482;, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:107%">RTDS&#174; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">(RTDS). Under the recent European Commission's proposal on regulation of plants obtained from new genomic techniques, such as the traits from the Trait Machine would be regulated as &#8220;conventional-like&#8221; (breeding).<br><br>Cibus believes that RTDS and the Trait Machine represents a technological breakthrough in plant breeding that is the ultimate promise of plant gene editing, a dedicated &#8220;industrial&#8221; breeding process at scale whose trait products are indistinguishable from conventional breeding or nature, and a process that provides the ability to change the scale and range of possible genetic solutions from breeding and with it, to develop the desired characteristics or traits needed for greater farming sustainability and food security with greater speed and accuracy.<br><br>The Company recently opened the Oberlin Facility which is the first dedicated Trait Machine facility. It is modeled on high quality biologics manufacturing processes from the pharmaceutical industry. The Trait Machine is crop specific. It is currently operational for canola, winter oilseed rape, and rice. Cibus plans to extend this to soybean. Cibus expects the soybean platform Trait Machine to be fully online in 2024. The promise is that, at scale and with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">the additional Trait Machine  crop platforms, Cibus will be able to launch important multi-crop traits simultaneously across multiple crops.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Because the Trait Machine is intended to be integrated into seed companies&#8217; breeding operations, the customer relationship between Cibus and seed companies with which it engages is a progressive relationship. Typically, the customer relationship is initiated with Cibus through the entry into a material transfer agreement pursuant to which seed companies transfer elite germplasm lines to Cibus for gene-editing and delivery back to the seed company for pre-commercialization testing and validation. Accordingly, Cibus refers to seed company &#8220;customers&#8221; in its disclosure once such a customer relationship has been initiated. At present, all of the Company's customers discussed in this press release are at this initial stage of a relationship. While this initial stage of such customer relationships is a necessary prerequisite to the entry into a revenue generating commercial contract with such seed companies, currently, Cibus has certain customer relationships which include commercial contract terms, as well as others that are in various stages of development, including some in trait evaluation and&#47;or field testing, however these have not yet generated revenue.<br><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">About Cibus</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:110%">Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability areas for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that develops and licenses traits to leading seed companies. The Company's focus is developing scale, multi-crop traits in the major global crops such as canola, rice, and soybean. Traits that can make a real impact in global agricultural productivity. Cibus is the technology leader in high-throughput gene editing technology with its Trait Machine. It enables Cibus to develop plant traits precisely and predictably at a fraction of the time and cost of conventional breeding. Cibus has developed a pipeline of five productivity traits including important traits for pod shatter reduction, disease resistance, and weed management. Its initial traits for pod shatter reduction and weed management are developed and are in commercial collaborations with leading seed companies. Its other pipeline traits, including </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:110%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:110%"> resistance, are in advanced greenhouse and field trial stages.<br><br></font></div><div id="ibe6757d4542747768b7e3606b76bd68b_120"></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:107%">Forward Looking Statements</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">This press release contains &#8220;forward-looking statements&#8221; within the meaning of applicable securities laws, including The Private Securities Litigation Reform Act of 1995. All statements, other than statements of present or historical fact included herein, including statements regarding the benefits of the Merger Transactions (defined below), Cibus&#8217; operational and financial performance,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">Cibus&#8217; strategy, future operations, prospects and plans, including the Company's projected cash runway, and the anticipated regulatory environment are forward-looking statements. Forward-looking statements may be identified by words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;intend&#8221;, &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;scheduled,&#8221; &#8220;could,&#8221; &#8220;would&#8221; and &#8220;will,&#8221; or the negative of these and similar expressions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">These forward-looking statements are based on the current expectations and assumptions of Cibus&#8217; management about future events, which are based on currently available information. These forward-looking statements are subject to numerous risks and uncertainties, many of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">which are difficult to predict and beyond the control of Cibus.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">Cibus&#8217; actual results, level of activity, performance, or achievements could be materially different than those expressed, implied, or anticipated by forward-looking statements due to a variety of factors, including, but not limited to&#58; risks associated with the possible failure to realize certain anticipated benefits of the merger between Cibus Global, LLC and Calyxt, Inc. (Merger Transactions)&#59; the effect of the completion of the Merger Transactions on Cibus&#8217; business relationships, operating results, and business generally&#59; the outcome of any litigation related to the Merger Transactions&#59; changes in expected or existing competition&#59; challenges to Cibus&#8217; intellectual property protection and unexpected costs associated with defending intellectual property rights&#59; increased or unanticipated time and resources required for Cibus&#8217; platform or trait product development efforts&#59; Cibus&#8217; reliance on third parties in connection with its development activities&#59; challenges associated with Cibus&#8217; ability to effectively license its productivity traits and sustainable ingredient products&#59; the risk that farmers do not recognize the value in germplasm containing Cibus&#8217; traits or that farmers and processors fail to work effectively with crops containing Cibus&#8217; traits&#59; challenges that arise in respect of Cibus&#8217; production of high-quality plants and seeds cost effectively on a large scale&#59; Cibus&#8217; need for additional funding to finance its activities and challenges in obtaining additional capital on acceptable terms, or at all&#59; Cibus&#8217; dependence on distributions from Cibus Global, LLC to pay taxes and cover its corporate and overhead expenses&#59; regulatory developments that disfavor or impose significant burdens on gene-editing processes or products&#59; Cibus&#8217; ability to achieve commercial success&#59; commodity prices and other market risks facing the agricultural sector&#59; technological developments that could render Cibus&#8217; technologies obsolete&#59; changes in macroeconomic and market conditions, including inflation, supply chain constraints, and rising interest rates&#59; dislocations in the capital markets and challenges in accessing liquidity and the impact of such liquidity challenges on Cibus&#8217; ability to execute on its business plan&#59; the Company's assessment of the period of time through which its financial resources will be adequate to support operations&#59; and other important factors discussed in &#8220;Risk Factors of Cibus, Inc.&#8221; filed as Exhibit 99.3 with Cibus&#8217; Current Report on Form 8-K, which was filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on June 1, 2023, under the heading &#34;Item 8.01 - Other Events - Supplemental Risk Factors&#34; in the Company's Current Report on Form 8-K filed on October 18, 2023, and any additional &#8220;Risk Factors&#8221; identified in Cibus&#8217; subsequent reports on Forms 10-Q and 8-K filed with the SEC. Should one or more of these risks or uncertainties occur, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. Cibus&#8217; assessment of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement and involves such risks and uncertainties. Accordingly, the Company could use its available capital resources sooner than it currently expects.<br><br>In addition, the forward-looking statements included in this press release represent Cibus&#8217; views as of the date hereof. Cibus specifically disclaims any obligation to update such forward-looking statements in the future, except as required under applicable law. These forward-looking statements should not be relied upon as representing Cibus&#8217; views as of any date subsequent to the date hereof.<br><br></font></div><div id="ibe6757d4542747768b7e3606b76bd68b_127"></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">CIBUS CONTACTS&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INVESTOR RELATIONS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Karen Troeber<br>ktroeber&#64;cibus.com<br>858-450-2636</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Jeff Sonnek &#8211; ICR </font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">jeff.sonnek&#64;icrinc.com<br><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">MEDIA RELATIONS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Colin Sanford<br>colin&#64;bioscribe.com<br>203-918-4347</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ibe6757d4542747768b7e3606b76bd68b_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CIBUS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited and in Thousands, Except Par Value and Share Amounts) </font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">September 30,<br>2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">December 31,<br>2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Assets</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">31,883</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">3,427&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Restricted cash</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">99&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Accounts receivable</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">560</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2,029</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">606&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total current assets</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">34,472</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">4,132&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Property, plant, and equipment, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">17,197</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">4,516&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Operating lease right-of-use assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">22,935</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">13,615&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Intangible assets, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">134,921</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">158&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Goodwill</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">585,266</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other non-current assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,444</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total assets</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">796,235</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">22,421&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Liabilities, redeemable noncontrolling interest, and stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accounts payable</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">6,281</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">340&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accrued expenses</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">5,092</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">173&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accrued compensation</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">3,704</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">107&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Due to related parties</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">175&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Deferred revenue</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,637</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">107&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Current portion of notes payable</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,165</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current portion of financing lease obligations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">235</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">97&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Current portion of operating lease obligations</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">5,436</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">367&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Class A common stock warrants</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,512</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">291&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other current liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">17</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total current liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">25,079</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,662&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Notes payable, net of current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">629</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Financing lease obligations, net of current portion</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">102</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Operating lease obligations, net of current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">18,844</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">13,447&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Royalty liability - related parties</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">157,113</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other non-current liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,974</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">79&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">September 30,<br>2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">December 31,<br>2022</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">203,741</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">15,188&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Redeemable noncontrolling interest</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">129,104</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Stockholders&#8217; equity&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Class A common stock, $0.0001 par value&#59; 210,000,000 shares authorized&#59; 17,656,831 shares issued and 16,659,996 shares outstanding as of September 30, 2023, and 978,912 shares issued and 976,908 shares outstanding as of December 31, 2022</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Class B common stock, $0.0001 par value&#59; 90,000,000 shares authorized&#59; 4,642,636 shares issued and outstanding as of September 30, 2023, and no shares authorized&#59; and no shares issued and outstanding as of December 31, 2022</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Additional paid-in capital</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">727,821</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">220,422&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Class A common stock in treasury, at cost&#59; 32,660 shares as of September 30, 2023, and 2,007 shares as of December 31, 2022</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(1,785)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(1,043)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accumulated deficit</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(262,664)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(212,151)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Accumulated other comprehensive income</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total stockholders&#8217; equity</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">463,390</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">7,233&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Total liabilities, redeemable noncontrolling interest, and stockholders' equity</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">796,235</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">22,421&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ibe6757d4542747768b7e3606b76bd68b_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CIBUS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited and in Thousands, Except Share and Per Share Amounts) </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Three Months Ended September 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Nine Months Ended September 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Revenue&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Revenue</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">475</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">42&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">714</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">115&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Total revenue</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">475</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">42&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">714</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">115&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">17,521</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,016&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">28,159</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9,207&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">8,751</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,229&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">22,126</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9,965&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total operating expenses</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">26,272</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6,245&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">50,285</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">19,172&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Loss from operations</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(25,797)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(6,203)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(49,571)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(19,057)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Royalty liability interest expense - related parties</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(8,136)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(10,753)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other interest income (expense), net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">281</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(47)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">359</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(80)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-operating income (expenses)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(876)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">300&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(466)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5,083&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Loss before income taxes</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(34,528)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(5,950)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(60,431)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(14,054)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income taxes</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net loss</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(34,528)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(5,950)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(60,431)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(14,054)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net loss attributable to redeemable noncontrolling interest</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(8,099)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(9,918)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net loss attributable to Cibus, Inc.</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(26,429)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(5,950)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(50,513)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(14,054)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Basic and diluted net loss per share of Class A common stock</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(1.59)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(6.36)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(6.33)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(15.56)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted average shares of Class A common stock outstanding &#8211; basic and diluted</font></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">16,641,127</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">935,702</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">7,979,132</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">903,476</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ibe6757d4542747768b7e3606b76bd68b_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgb.jpg" src="cibus_logoxrgb.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CIBUS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited and in Thousands) </font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:75.304%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.656%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Nine Months Ended September 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Operating activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(60,431)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(14,054)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Adjustments to reconcile net loss to net cash used by operating activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Royalty liability interest expense - related parties</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">10,753</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2,875</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,158&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock-based compensation</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">11,670</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2,890&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Change in fair value of liability classified Class A common stock warrants</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,221</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(5,009)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">17</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Changes in operating assets and liabilities, net of acquisitions&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts receivable</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,674</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Due to&#47;from related parties</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(95)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(34)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,111</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">297&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(61)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(188)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accrued expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,357</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">41&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accrued compensation</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">738</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(166)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred revenues</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">340</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(115)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets and lease liabilities, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(28)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">154&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other assets and liabilities, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(334)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(575)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash used by operating activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(29,193)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(15,601)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash acquired from merger with Cibus Global, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">59,381</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchases of property, plant, and equipment</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(3,872)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1,509)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net cash provided by (used) by investing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">55,509</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1,509)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Financing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Proceeds from Class A common stock issuance</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11,209&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Costs incurred related to the issuance of Class A common stock</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(962)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Proceeds from draws on revolving line of credit from Cibus Global, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2,500</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Payment of taxes related to vested restricted stock units</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(742)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Proceeds from issuance of notes payable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,287</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Repayments of financing lease obligations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(242)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(353)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Repayments of notes payable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(760)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash provided by financing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2,043</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9,894&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Effect of exchange rate changes on cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(2)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net increase (decrease) in cash, cash equivalents, and restricted cash</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">28,357</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(7,216)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash, cash equivalents, and restricted cash &#8211; beginning of period</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">3,526</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">14,421&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash, cash equivalents, and restricted cash &#8211; end of period</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">31,883</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7,205&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cbus-20231109.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:196cb9eb-1bde-4e17-8bc6-1a55435101d8,g:12ddaaee-0dde-4278-a13c-9fa8a1d555be-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cbus="http://www.cibus.com/20231109" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cibus.com/20231109">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cbus-20231109_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cbus-20231109_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.cibus.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cbus-20231109_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:196cb9eb-1bde-4e17-8bc6-1a55435101d8,g:12ddaaee-0dde-4278-a13c-9fa8a1d555be-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_92463d41-e2f9-48b1-8b73-e8ab8ee5dd95_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3356d019-f864-4b41-a2a2-4e1595825262_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_b84519a3-1691-4ddd-bee7-c156caae8b60_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b5ddacb2-2c06-4314-a2c6-80831e8a403b_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_3db139f9-79cc-4c96-973a-6b02a712be4f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_085f4808-8306-42a2-be0b-c5bd5787b85e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a3e4eaed-2f55-4192-b0e8-fcc2378b67a4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_e3e5626e-43a0-4ec3-8c14-0b7ea71c620a_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_be8eb522-a06b-4357-908a-fa1547cde92a_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_fa327a44-1834-4fbc-8cd3-47bae6ca20dd_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_60eb9b32-6b39-40fd-8ca8-1df73391baa8_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_eb09b74a-8fd3-4e32-a3ce-fde584fcfe53_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5086f966-8657-4895-aaa8-ab6998b3903b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f02ac71d-ed42-4bec-a548-5f5f2401978a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b87421b4-ec11-46f5-b8aa-5e6623249ac1_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_40e137f2-2211-42e3-9b38-a15edf353ed4_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0628487b-0810-4b69-bf96-a39b552ff3fa_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_76b1a5f7-0742-4321-b04d-08850521275e_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d1e4a84f-b3a7-41da-bb99-8fb560ec8d19_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_bfcfbe24-9656-4997-a34e-0a8ddc50a2f7_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_68a8df55-43e9-4c86-adf7-cbe8112b5892_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_44b75952-d429-4247-bd8d-a3f90af69929_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cbus-20231109_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:196cb9eb-1bde-4e17-8bc6-1a55435101d8,g:12ddaaee-0dde-4278-a13c-9fa8a1d555be-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cibus.com/role/Cover" xlink:type="simple" xlink:href="cbus-20231109.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.cibus.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_9f2f9cd7-c020-42d3-8de5-06a30d443989" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_DocumentType_9f2f9cd7-c020-42d3-8de5-06a30d443989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d6fc2881-a4fa-4508-bd55-23b8c0914a39" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_DocumentPeriodEndDate_d6fc2881-a4fa-4508-bd55-23b8c0914a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_4efb3dc0-e49b-4014-a765-3f42279fb336" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_EntityRegistrantName_4efb3dc0-e49b-4014-a765-3f42279fb336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_5c280376-dbdc-4801-af3c-58cddd48a7d0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_EntityIncorporationStateCountryCode_5c280376-dbdc-4801-af3c-58cddd48a7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ef4a0071-ce1c-4c46-ae3b-8766efa2b7a6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_EntityFileNumber_ef4a0071-ce1c-4c46-ae3b-8766efa2b7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f5ebf726-9689-417e-9589-2b8ed4922f11" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_EntityTaxIdentificationNumber_f5ebf726-9689-417e-9589-2b8ed4922f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e8286af8-0676-4898-b5b9-f4a0bd9c28d2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_EntityAddressAddressLine1_e8286af8-0676-4898-b5b9-f4a0bd9c28d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_102cdfe9-8cb8-421a-875d-7bc3103caaad" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_EntityAddressCityOrTown_102cdfe9-8cb8-421a-875d-7bc3103caaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_4d431f32-c538-4c23-bf16-3b68d8a0f4f5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_EntityAddressStateOrProvince_4d431f32-c538-4c23-bf16-3b68d8a0f4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1c764050-3af6-4304-af3c-ed991cdb5d00" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_EntityAddressPostalZipCode_1c764050-3af6-4304-af3c-ed991cdb5d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_062e215c-5e5f-452f-8c81-7cca69d9b9c1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_CityAreaCode_062e215c-5e5f-452f-8c81-7cca69d9b9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_51b5f07f-cf66-416b-94f8-f762676520c2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_LocalPhoneNumber_51b5f07f-cf66-416b-94f8-f762676520c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_db56fb8b-64a9-49d1-9393-588590aa4eb4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_WrittenCommunications_db56fb8b-64a9-49d1-9393-588590aa4eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_cf7d5125-f70b-42ba-be42-01ea6a0678aa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_SolicitingMaterial_cf7d5125-f70b-42ba-be42-01ea6a0678aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_c7399426-4dd0-4b0a-88e4-018179f40711" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_PreCommencementTenderOffer_c7399426-4dd0-4b0a-88e4-018179f40711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_81b13957-c002-46af-b470-3ac6b98ed625" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_81b13957-c002-46af-b470-3ac6b98ed625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b74d57fb-461d-4077-9226-c7473108e40d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_Security12bTitle_b74d57fb-461d-4077-9226-c7473108e40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ad97821b-c4c5-4145-a287-3102356a79d9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_TradingSymbol_ad97821b-c4c5-4145-a287-3102356a79d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_017d6f09-d325-49de-ad2e-db01fbcd0cee" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_SecurityExchangeName_017d6f09-d325-49de-ad2e-db01fbcd0cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ad791ac4-ec4b-4098-a8b3-497c3ae295f2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_EntityEmergingGrowthCompany_ad791ac4-ec4b-4098-a8b3-497c3ae295f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_99cd8842-aabd-4d90-8036-5af962bcd8f0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_EntityCentralIndexKey_99cd8842-aabd-4d90-8036-5af962bcd8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a97242b1-51e7-4c90-b983-661d7e0fc94b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b3c548-37ef-411e-b5ca-80939696f288" xlink:to="loc_dei_AmendmentFlag_a97242b1-51e7-4c90-b983-661d7e0fc94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>cibus_logoxrgb.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cibus_logoxrgb.jpg
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M  (1 0,1 ?_$ /(  0 # 0$! 0             %!@<$ P(! 0$! 0$! 0$
M            !00# @$&$  ! @0% P0" @$% 0     # 0( $ 0%(#! $3$R
M$P8A$C0U4!1P,Q9@(B,5)201  $" 00-"@4# P,#!0    $" P @$2$Q,$!!
M47&QP1(B,E)R!&&!D:'1X8(3(S,00F*2LE"B%'#Q4V#P--)#8W.#DZ,D$@ "
M  0' 0$            1(4!08'  $" P@) !,: 3 0 ! @()! ,! 0$
M  $1 #$@(3! \$%187&AL1"!D<%0T>'Q<&#_V@ , P$  A$#$0   =4
M             'SY!8<41DQ^?GSW=^]BH4>CKT
M                                                   K,R9 3\
M]??JZ6K79V[
M                       "@P('AS\ >_3WU=>OCX\7FY<_?OT
M
M  "DQ(G!GX 3V_?9:5&A085EITIK;M
M                                          Y./&H2)')QY='3I<[5
MGJZ]:O+E\_/G<+%@
M                            #S\^?3UZ A<.*O3Y][O70
M
M   (G'DJ\R7?K]\
M                         "*R9(W-F[>_>7UZ_OUZ $%@P0F+%>+EP
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MTY^WG[X^GCK\>_OY]^_BX8=H  $1WXYK5F1'?B     /OY]UN)7FN'<
M "!P8*Q+F"8V;+;7K<O'C1(4.^W[W1TZ      "-Z\L9O10   /3Y]T271N&
M':        !DMJ1 Z<X&O1+$UG[@   "G[L6;U9H%UP;M#ET0      !7=6;
M+[$OQ^^0   +%ETZE'J^GSZ  ,UK3+W-WT.E/T.72S2M,TZ13RZQ+U:-6  %
M3VX\WJS?/[\      &KQJUARZ0      (?'CJ4B2/WZOU^_"XL4-BQWF[<
M     C>O+&;T4    ?IIDBI:\>L        9+:D0.G.!KT2Q-9^X    I^[%
MF]6:!=<&[0Y=$      ")[<<BN1_+[\     M>/7ILBH  ,QKR]#ET<\J3OQ
M\FL_>ZX-V36I&LQ:X %.W8LYJS?P $CRZ6K'KF\_?NY]/OXY/?F'[\*SKS06
MG/\ @-7C5K#ET@      1&/'49$D"V5JT#@P2>K39*5(      "-Z\L9O10.
MOQ[MV+7\'!UYU[3G\?7D#H\^MG@VNGQ[        R6U(@=.<#7HEB:S]P
M!3]V+-ZLT"ZX-VARZ(      &2VY$#HS@?3[<L&RT8]?7X]<73Q4-V.J;,@
MU6-6L>72 !4-V,0>CAH\JEFE:7;<6R#T<+]-H "NZLV5V9/R ='GUH4NC;<6
MO]?0  (GMQSZI.KVG/J\:M8<ND      "(QXZC(D@2^S7$8\EXN6^WOW
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M\=1D20!.[]UHJ5       !&]>6,WHH$OQ[;#"L@ 8[=C1/;B/7Y]W/\ .W@
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M>[6[8       $;UY8S>B@2_'ML,*R.?UYJVS)G].?X>O(]OGK9(-GNY]
M    ,EM2('3G UZ)8FL_<    4_=BS>K- NN#=H<NB      !\OF6V95;U9@
M !-Y^]RP[;3BU?3Z       !#=^&07(X$SP[:_#L@              "(QXZ
MC(D@2VO5;[%@       "-Z\L9O10/M]Z?'KS^_/#UY_ #]-1CU;-DU
M  #);4B!TYP->B6)K/W    %/W8LWJS0+K@W:'+H@      #Y^_,]ISJ9OQ?
M@  )#GTT*71LV34       *YJS959D@63+IU2-6               $1CQU&
M1) F=NRV5JP       $;UY8S>B@    2_'MH<NC/9M        &2VI$#IS@:
M]$L36?N    *?NQ9O5F@77!NT.71        $+WX4.E@KVK-^   M^'9H\JE
M]/H      KFK-E5F2!9,NG5(U8               1&/'49$D":V[;76J@
M     1O7EC-Z*     /HTB33MV+8       ,EM2('3G UZ)8FL_<    4_=B
MS>K- NN#=H<NB         (WKRIN_%4MN3P]>0 +9BUZ9)J      "$T<,BM
MQP)GAVU^'9               $1CQU&1) FMNVUUJH       $;UY8S>B@=W
M/I>IVX?/UR^_$/WXU_3G\_OP#[?==AV)CAV       R6U(@=.<#7HEB:S]P
M  !3]V+-ZLT"ZX-VARZ(          \?7FF;\5&HX?'[Y &IQZMER:@
M.3WXQ+]!# ]?GW<?SUWZ^?0              (?%CJ4F2!-;=MKK50
M (WKRQF]% E^/;885D #BZ<\ML2H;OQ L&;1K$6N      !DMJ1 Z<X&O1+$
MUG[@   "G[L6;U9H%UP;M#ET0          !&]>63VI/#TY@3N?OK<2P
M  ,6OQ.#IS U:-6L672              !"XL54DR@)K;MM=:J       !&]
M>6,WHH$OQ[;#"L@ #C]^,9OQ?'[Y'Z;9^?N=?CV      ,EM2('3G UV)8F\
M_<    4S?BSJI- NN#=H<NB           ! :<^36I 'T^[C^=N>OST
M!G-6;3=V("QY=.JQJP              $+BQ523* FMNVUUJH       $;UY
M8S>B@2_'ML,*R  !E]B55]>4#5XU:PY=(      RFS)KNK,!J4>K9LFH
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M6   /Q\Q']##YO7D#;OS]SJ\>P     !P].>.78WAZ\@=OCWJD:M+\.P
M\OOG-ZTVV8M=ARZ0      (C'CJ,B2!-;=MKK50       (WKRQF]% E^/;8
M85D  0&G/D]J1^ _3;?S]SJ\>P     !Q^_&*_H(GR^ :C(JV?'J   % ISZ
M-0P =_/IM,"V      (SMRQJ[% ^GW:(%KNY]  !6M>7++$H#NY]-J@6P
M   !6=>7+K$K\ /3Y]O,[?=<&WV\^@  *SKRY[4G1_3GJ\:M8<ND      ".
MS9J7%C 36W;:ZU4       "-Z\L9O10)?CVV&%9 'E]\U/;DSZG/\?7D"Q9=
M.K1JP       S2M,J6W&![?/NFR*EER:@ !1Z&"@4Y_X :-+I7+!M
MQZ[&B.W$"<S]]6C5O;SZ $;UY9+;D<?OP!=Y^[09E$       "G;L6<U9OX
M#W\^K)DTSF?OW<^GT<_KS$]N59V98SKR U>-6L.72      !Y^/&?P('Y\":
MV[;76J@       1O7EC-Z*![?/4QG[#\^_.?UYC>O/X^_ !Z?/NO0[$MQ[
M     #E]^,=NQN/WX _2?S:+-DU2'+I\D7VXU7;EB>W$ 3>?OKD2O^OH
M  %8UY<NL2@!W\^EPP[);AV^?OR"T<*?NQ^/KR!T>?6RP;77X]@       "K
M[,F:UIGC]^      #5XU:PY=(       I<2+'9\XFMNRUUJP       $;UY8
MS>B@    #Z?=,D4[5CU@       "&[\,HM2>?UY     $ERZZW$K]?CV
M   !E]>55]F4    #Z-/CU;/DU         ".Z\LXJS:_IS@    #L\>]8BU
MY3CU       $3DR5"/($GJTW*S9        C>O+&;T4    #M\>])DT[%ET@
M        "*[<<OL2XSKR    %AS:-.D5.GQ[        'G]^9A7E5K7F
M]?GW2I-.TX]8          $#IST_=CK>K-X^O(  ^GV<S=[9BUVK'K]/GT
M      5"/(B<F3[]?;U=N]'3H       (WKRQV[&  'T>OGUV>/<GQZV#-HM
M.+5Z_/0          ^/ORE[\5-WXN#IS  $QP[7:?NM6/6          *CMQ
MT:C@CNO, #[^?;-DTWZ;0D>74            ?+Y%=^4;UY<WOS\G1Y^]_+I
M+\>WMY]          ?'GS594J'QY/7WZE]>RTU:@
M     $7VXQ/;ES>_/Z=G/W,<.W=SZ            "*[<8GMRY_?GZ^._GTF
ML_?H\^@                            (S+EC,V;T]>K%1H@
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M.0RD&M-<*A3?E2VNWEA_CE L+XQ3PGC--#/'K<V T-&'5FM=O-#_ !N@6/\
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MYA\5%I/>'\1(8P'&;&UOY#(>W1CL\VTL#+DD-).JG2/-+*32#01"L]<W#SZ
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M )C^%,Y.>U#V+4RA;<RQSO.]6R<;;%I,_P!U#3%NPCO-/(W%>'W@@/@O+Z_
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MDDDEVT>DDDDDDDB__P#_ /\ \DDDDDDDDDW_ +))))(_^)))))))) /_ /\
M_P#I))(,UFI))&O_ /\ _P#_ /\ ,DDDDDDD&UD4DDDDDDD7_P#_ /\ [TDD
MDDDDDDF_]DDDDD?_ !)))))))&?_ /\ _P#^)))!@^/)).__ -FR[Y_F2222
M222';;62222222+_ ..&_P"C))))))))-_[))))(_P#B2222222#_P NHO\
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M !))))))).?_ /\ 0\DDDDDDDD?_ ')))))))))))))))(=LY)))))))(O\
M@E_^J222222223?^R2222/\ XDDDDDDDD+__ /\ U22222222;_F22222222
M22222220[:R22222221?_P#_ /\ \622222222;_ -DDDDD?_$DDDDDDDDG3
M_P#_ -.2222223?^R222222222222222';:22222222+_P#_ /\ _P#.DDDD
MDDDDW_LDDDDC_P"))))))))))%=__P#R222222#_ -DDDDDDDDDDDDDDDD.V
MTDDDDDDDD7_3<-7_ !))))))))O_ &22221_\222222222226C_\R222221?
M^F222222222222222+;:22222222+_B22%_^R2222223?^R2222/_B222222
M222221K_ -DDDDDDD7_LDDDDDDDDDDDDDDDNVTDDDDDDDD7_ !)))A_]))))
M)))O^)))))%_Y))))))))))))%_QY))))))/^I)))))))))))))))=MI))))
M)))(O^)))(?_ &2222221?\ \DDDDF_^DDDDDDDDBDDDD/\ ]))))))(_P#^
M222222222222222[;222222221?\2223_P#LDDDDDD@_ZDDDDDW_ /))))))
M%6I))))/_9))))))%_[Y))))))Y)))))))=MI)))))))(O\ B222;_V22222
M21_^R2223[_B222222/_ -DDDG/_ +))))))(M_R)))))'3)))))))#MM)))
M)))))%_Q))(G_;)))))))I_Q)))(/_!))))))!_XI))+_P#22222222*_P#>
MLDD@QYDDDDDDDGVVDDDDDDDDB_XDD_W_ %))))))))/^3)) W_Q)))))))!_
M[9)/?_Y)))))))([_P#[M%X?\R2222221G;222222221?^;5[_\ 7DDDDDDD
MD)_[L&X__P Y))))))(O_P 57;_I222222222$__ /\ _P#_ /YDDDDDDDD6
MQDDDDDDDDB__ /\ _P#_  I)))))))).O_\ _P#_ /XI))))))))_P#_ /\
M_P#G2222222222,__P#_ /\ _P!DDDDDDDDDVLDDDDDDDD7_ /\ _P#_ #9)
M))))))))*/\ _P#_ /R9))))))))(_\ _P#_ /;)))))))))))*M_P#_ ,VD
MDDDDDDDDFQDDDDDDDDG_ /\ \X >222222222202?_\ _P")))))))))) O_
M /\ 3,DDDDDDDDDDDDC#&?LDDDDDDDDDD[U4DDDDDDDDDDDDDDDDDDDDDDDD
MDD/$5DDDDDDDDDDDDD^7&DDDDDDDDDDDDDDDDDDDDDDDDDDDDDA-DDDDDDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDG_V@ ( 0$# 3\0
M_"NG *C !=6B"Y15)\A]%33E#A[QY5+ 9G,#X"5N\=1U,L_2FZ5K)7=]EO\
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M46=?JB/A@9L1[[*_"B@%MUG6#[U+9_'I(783*YP"S[Y1"V)"2-W)]L#RC/\
M,=.C("Y\,C$2WV&?!*:N,'#Q9W.B!QI%(0F2-QQY9"SA=TW2X7-W"@\@0 $B
M%QTXL,1G.1@,NISWA"E^7*(VS^/2G_(@H)$3,1IR L$!,^1,^3._YGIT9 Z,
MVR]XY63A(J*T9D9\CS:-CJRVAOED.9EBF!PW];+O;-SU3IF+,FL3$KV6!$(/
M?0N_Y<HC;/X\!@O1$1%D@F[U,,==S-!1T*"B!=T/O*9T)EDATT>0:2VT*ES
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MEG1 %M_2@ EG_B2IP<SWP3\*1\T+*S2*]S4@[^#_ ,2@;?<TUDRX[O1&!^J
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FNXCQXI=D5SU&\7:MW3U:L8/SC><=0-;J3W_BCTA.1E?Y?_7?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140167493269072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 09, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  09,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cibus, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-1967997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6455 Nancy Ridge Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">450-0008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CBUS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001705843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>cbus-20231109_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cbus-20231109.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001705843</identifier>
        </entity>
        <period>
            <startDate>2023-11-09</startDate>
            <endDate>2023-11-09</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001705843</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-11-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Cibus, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-38161</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">27-1967997</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">6455 Nancy Ridge Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">450-0008</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Class A Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">CBUS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M#O< W%\I9=\';MM:_M=A]!]02P,$%     @ (H%I5Y^@&_"Q @  X@P   T
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( "*!:5?#B7P(200  ($0   8
M          " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    "  B@6E7GZ ;\+$"  #B#   #0              @ &,#   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( "*!:5>7BKL<P    !,"   +
M  "  6@/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( "*!:5>JQ"(6,P$  "("
M   /              "  5$0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M"  B@6E7)!Z;HJT   #X 0  &@              @ &Q$0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  B@6E799!YDAD!  #/ P
M$P              @ &6$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"  #@$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cbus-20231109.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cibus.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="cbus-20231109.htm">cbus-20231109.htm</File>
    <File>cbus-20231109.xsd</File>
    <File>cbus-20231109_lab.xml</File>
    <File>cbus-20231109_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cbus-20231109.htm": {
   "nsprefix": "cbus",
   "nsuri": "http://www.cibus.com/20231109",
   "dts": {
    "inline": {
     "local": [
      "cbus-20231109.htm"
     ]
    },
    "schema": {
     "local": [
      "cbus-20231109.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cbus-20231109_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cbus-20231109_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.cibus.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cbus-20231109.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cbus-20231109.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001628280-23-038235-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-038235-xbrl.zip
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M+SF=8"M/[7GPXM2-_)#F:X=O4E%G[DP*#7^QJTC4 6:YPB^4>4;+_"=3I@8
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MC)P0<Q/)IJ!1Y:32VY8V:;PI'P$HL66I@-@:'L*K,B(;P#:J*")S[KDXN/-
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M#WDLG<>,\)W8:MO)&97%L,T'$QR,N5!)QSW*E%F5G*C8P;@*C>]R?)2Q35W
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M@FKT<>;?D6<MX,<TG#GO_P]02P,$%     @ (H%I5^3'@_82#P  ;FH  !$
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M#4\ #HA!.,[;>A!\1??X'>;=.$; LOXF$\Q6I?3R,5BM9-GEKQV#O8!?\ E
M(WCY;!EVW(V\S4^"*Y!:S*LD8999D$^6%SI%H[$027Q9 F9U +L-(Y"Q!6B8
MY0N)9S;BVPDH5,DM9[KZ8(,;][4/G IIOFL3MVA;T'&)>[91,=DSG-?%RK)O
M1K [$;@ ,!=A_P/8;S#BP=-277KC4CWE"1EF3%D4::=$P=>=D>JY6HV)3)?
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MVL2[R;B1^Y^GK];O),N?TCY]]7]02P,$%     @ (H%I5PLWQ'NI!@  V#
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MLOYF\42\,]QPM'>_H_UH7X0_VOL_4$L! A0#%     @ (H%I5T#,P<B$/
MZ=T" !0              ( !     &-B=7,M,C R,S Y,S!X<'(N:'1M4$L!
M A0#%     @ (H%I5^3'@_82#P  ;FH  !$              ( !MCP  &-B
M=7,M,C R,S$Q,#DN:'1M4$L! A0#%     @ (H%I5YU:9NYD @  9P<  !$
M             ( !]TL  &-B=7,M,C R,S$Q,#DN>'-D4$L! A0#%     @
M(H%I5Y'>K^-)"@  &ET  !4              ( !BDX  &-B=7,M,C R,S$Q
M,#E?;&%B+GAM;%!+ 0(4 Q0    ( "*!:5<+-\1[J08  -@P   5
M      "  099  !C8G5S+3(P,C,Q,3 Y7W!R92YX;6Q02P4&      4 !0!&
) 0  XE\

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
